Clinical Research Education for Drug Abuse Professionals

药物滥用专业人员的临床研究教育

• 批准号: 8433405
• 负责人: Thomas Frederick Newton
• 金额: $ 22.25万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-03-01 至 2016-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8433405
• 关键词: Accountability; Address; Applications Grants; Area; Behavior Therapy; Brain imaging; Clinical; Clinical Research; Clinical Trials; Collaborations; Communities; Competence; Drug Addiction; Drug abuse; Education; Educational Curriculum; Educational process of instructing; Ensure; Environment; Ethnic group; Evaluation; Faculty; Funding; Goals; Grant; Health Professional; Health Services Research; Home environment; Hospitals; Human; Immersion Investigative Technique; Institution; Investigation; Journals; Knowledge; Manuscripts; Medical center; Medicine; Mentors; Methods; National Institute of Drug Abuse; Peer Review; Pharmaceutical Preparations; Pharmacology; Pharmacotherapy; Physicians; Population; Postdoctoral Fellow; Psychiatrist; Publications; Reporting; Research; Research Infrastructure; Research Methodology; Research Personnel; Research Training; Residencies; Site; Techniques; Technology; Testing; Texas; Training; Training Programs; Training and Education; United States National Institutes of Health; Universities; Validity and Reliability; Woman; Writing; addiction; base; clinical practice; cognitive neuroscience; college; drug abuse education; experience; forging; improved; innovation; medical schools; meetings; neurochemistry; neurogenetics; pre-clinical; programs; public health relevance; racial and ethnic; response; symposium

DESCRIPTION (provided by applicant): This new application is submitted to initiate a Clinical Research Education for Drug Abuse Professionals (CREDAP) training program at Baylor College of Medicine, based on the successful CREDAP that was previously sited at UCLA. The overarching goal is to provide a coordinated, sustainable infrastructure of dedicated education and training that will produce independent healthcare professionals capable of conducting and disseminating clinical research pertaining to drug dependence and its treatment. This extensively revised application features an expansion of available mentors and research opportunities to include Pre-Clinical Human Pharmacology and Medications Testing (Drs. Newton, De La Garza), Brain Imaging and Cognitive Neuroscience (Drs. Moeller, Lane, and Steinberg), Neurogenetics (Dr. Nielson), Neurochemical Correlates of Addiction (Dr. Little) and Clinical Trials Research (Dr. Kosten). In addition, the program includes more extensive mechanisms of ensuring accountability of both faculty and trainees with the goal of consistently producing trainees that are able to successfully compete for funding. The specific aims of the program are: 1. to provide trainees with a comprehensive understanding of drug abuse research and clinical practice, entailing interdisciplinary clinical research education and training lasting two years at post-doctoral level under the guidance of preceptors. 2. To educate trainees to have full competence in using experimental techniques appropriate for the investigation of drug abuse, emphasizing advanced technologies, procedural reliability, and validity. 3. To encourage trainees to investigate a defined clinical research issue in drug abuse, with a focus on clinical trials research, starting them on a course of clinical research that will continue beyond the 2-year program. 4. To prepare trainees to become productive clinical researchers by teaching them to prepare manuscripts reporting research results that merit publication in peer-reviewed, high-quality biomedical journals, to write and submit grant applications to the NIH, and to become part of national research communities by attending meetings, seminars, and symposia where they may present research, gain new knowledge, and forge new collaborations. 5. To increase diversity in the training program through identifying and soliciting applications from promising candidates from underrepresented populations, including racial/ethnic groups and women. 6. To further develop and refine the program through formal evaluation efforts that provide input on areas that can be improved.

描述（由申请人提供）：根据以前在UCLA的成功信用，提交了此新申请，以启动贝勒医学学院的药物滥用专业人员（Credap）培训计划的临床研究教育。总体目标是提供专门的教育和培训的协调，可持续的基础设施，以产生能够进行和传播与药物依赖及其治疗有关的临床研究的独立医疗保健专业人员。这项经过广泛修订的应用程序具有可用的指导者和研究机会的扩展，包括临床前的人类药理学和药物测试（牛顿博士，De la Garza博士），脑成像和认知神经科学（Moeller，Lane和Steinberg博士），Neuurenogentics，Neuronetics（Nielelson）（Nielson），Niurochemical Cornical Cornictical（Neurochemical Cornicticals and undictical and Brine）和B. Brick and tr. Kerst and Brine and tr. Kerst and Brine）和Korst and Brine and tr. Korst and Brine and Kist and Brine and Kersectic and Brine）。此外，该计划还包括确保教师和学员问责的更广泛的机制，目的是始终如一地生产能够成功竞争资金的受训者。该计划的具体目的是：1。为受训者提供对药物滥用研究和临床实践的全面了解，需要在教育者的指导下在博士后阶段持续两年的跨学科临床研究教育和培训。 2。教育学员有能力使用适合调查药物滥用的实验技术，强调先进技术，程序可靠性和有效性。 3。鼓励受训者研究药物滥用方面的临床研究问题，重点是临床试验研究，从他们开始的临床研究课程将持续到2年的计划之外。 4.为了使学员做好准备，以教导他们准备手稿报告研究结果，以表彰他们在同行评审，高质量的生物医学期刊上出版的成果，以将授予申请撰写并提交给NIH，并通过参加会议，研讨会和介绍性来获得新知识，并获得新知识，并获得新知识，并获得新知识，并获得新知识，并获得新的知识，并获得新的知识。 5。通过从代表性不足的人群（包括种族/族裔群体和妇女）中识别和征求有希望的候选人，通过确定和征求培训计划的多样性。 6。通过正式评估工作进一步制定和完善该计划，这些工作为可以改进的领域提供意见。